Buys
Open market- Shares
- Avg price
- Total value
Elvia Cowan - SVP, Finance & CAO at Vaxcyte, Inc.
Issuer-level insider activity
- Role
- SVP, Finance & CAO
- Issuer ticker
- PCVX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Elvia Cowan in Vaxcyte, Inc.
Sells
Open market- Shares
- -19,015
- Avg price
- $51.99
- Total value
- -$988,601
Net
Past year- Shares
- -19,015
- Share %
- -100%
- Total value
- -$988,601
Reported holdings for Elvia Cowan in Vaxcyte, Inc.
Form 4 holding
SVP, Finance & CAO
Vaxcyte, Inc.
- Security class
- Common Stock
- Shares / value
- 28,975
- Estimated value
- $1,738,500
- Report date
- 07 Apr 2026
- Price
- $60.00
- Ownership
- Direct
Form 4 holding
SVP, Finance & CAO
Vaxcyte, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 93,068
- Estimated value
- Report date
- 07 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Elvia Cowan in Vaxcyte, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.